![Bervin Bouani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bervin Bouani
Direttore/Membro del Consiglio presso
Germitec SA
Profilo
Bervin Bouani currently works at Turenne Capital Partenaires SA, as Investment Director from 2014, Germitec SA, as Director, Antabio SAS, as Director, and Mablink Bioscience SAS, as Director from 2021.
Posizioni attive di Bervin Bouani
| Società | Posizione | Inizio |
|---|---|---|
Turenne Capital Partenaires SA
 Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital invests in small and middle market companies located in France. The firm focuses on healthcare, hospitality, environment, energetic transition and innovacom sectors. It participates in seed, early and later stage transactions with an investment size of less than EUR 30 million. | Investitore di Private Equity | 01/06/2014 |
Antabio SAS
 Antabio SAS Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs | Direttore/Membro del Consiglio | - |
Germitec SA
 Germitec SA Medical SpecialtiesHealth Technology Manufactures UV-C disinfection devices | Direttore/Membro del Consiglio | - |
Mablink Bioscience
 Mablink Bioscience Pharmaceuticals: MajorHealth Technology Manufactures antibody-drug conjugates | Direttore/Membro del Consiglio | 01/04/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
35
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Turenne Capital Partenaires SA
Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital invests in small and middle market companies located in France. The firm focuses on healthcare, hospitality, environment, energetic transition and innovacom sectors. It participates in seed, early and later stage transactions with an investment size of less than EUR 30 million. | Finance |
Germitec SA
Germitec SA Medical SpecialtiesHealth Technology Manufactures UV-C disinfection devices | Health Technology |
Antabio SAS
Antabio SAS Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs | Health Technology |
Mablink Bioscience
Mablink Bioscience Pharmaceuticals: MajorHealth Technology Manufactures antibody-drug conjugates | Health Technology |
